[Remote] Pathology Support Coordinator - Sample Review (Tues-Sat 2nd Shift) at Natera

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

BS/BA degree (preferred)
High School Diploma (or equivalent) required
2+ years of medical industry related experience - pathology preferred
Previous data entry experience is required
Trained on all product types
Ability to QC with high accuracy and efficiency consistently
Typing speed of at least 45wpm with high accuracy
Excellent oral and written communication
Excellent critical thinking skills and the ability to use good judgment
Ability to perform required duties with a high degree of accuracy and attention to detail
Positive attitude and ability to work well with others

Responsibilities

Review cases for accuracy and completeness of pathology tissue samples for Signatera and Altera testing
Interpret pathology reports, clinical notes and additional testing reports to complete light data entry for each tissue sample
Collaborate with team members to work to resolve potential discrepancies
Ensure that necessary notes and holds are placed on cases for non-conforming samples, discrepancies and/or missing information and escalated to ensure timely resolution
Confirm cancer types for the reporting team before the report is issued via emails and spreadsheet
Meet daily case metrics
Attend interdepartmental meetings
Provide feedback on the current process or workflow
Review and understand all SOPs
Complete training relating to HIPAA/PHI privacy

Skills

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free